Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis

Author(s):
Daalen, E.E. van; Rizzo, R.; Kronbichler, A.; Wolterbeek, R.; Bruijn, J.A.; Jayne, D.; Bajema, I.; Rahmattulla, C.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2017), Vol. 76, no. 6, p. 1064-1069
hdl
1887/115925
doi
10.1136/annrheumdis-2016-209925